Novo Nordisk A/S stopped two more trials for its experimental heart disease medicine, in a further blow to the drug’s ...
New 2026 ESC guidelines explain how cardiovascular and kidney disease influence each other and recommend wider kidney ...
India's heart valve disease burden and TAVI adoption are growing, but access, awareness, and reimbursement issues need to be ...
New ESC guidelines highlight the close connection between heart and kidney health, urging cardiovascular patients to undergo kidney screening and receive timely treatment to reduce serious health ...
AIIMS probes a 15-year-old’s death after years of congenital heart disease care, highlighting the challenges of treating ...
Welltica+ on MSN
Your sleep quality could be raising your heart disease risk
Nearly 1 in 3 adults is sleep-deprived, and now it counts as a core heart-health risk.
Morning Overview on MSN
Loneliness may raise heart-disease risk about as much as smoking
Doctors have spent years warning about high blood pressure, poor diet and smoking as drivers of heart disease, but a growing ...
Novartis faces setbacks as its heart drug pelacarsen fails final trial, impacting shares and raising questions on cardiovascular treatment benefits. Read more at straitstimes.com. Read more at ...
Novartis faces second trial setback as heart drug pelacarsen fails to reduce heart attacks or strokes, shares drop.
A Laredo family's fundraiser has surpassed its $250,000 goal as 5-month-old newborn Juan Diego recovers from a more ...
New USDA dietary guidelines call for more use of full-fat whole milk . But is this actually healthier than low-fat milk?
Novartis is counting on a string of new medicines to sustain growth when some of its biggest products lose patent protection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results